Search results for " Benign Fibrous"

showing 10 items of 10 documents

CD99 Immunoreactivity in Atypical Fibroxanthoma

2002

Atypical fibroxanthoma (AFX), a pleomorphic superficial cutaneous tumor of low-grade malignancy, shares many morphologic features with malignant melanoma (MM) and squamous cell carcinoma (SCC). Absence of S-100, keratin, and desmin immunoreactivity is the clue for this diagnosis. In a search for positive markers, we tested 26 cases of AFX with 2 antibodies: O13 (CD99) and protein gene product 9.5 (PGP9.5). We also included 10 cases of poorly differentiated SCC and 10 cases of MM in the study. In AFX, CD99 immunoreactivity was present in 19 cases (73%), whereas focal PGP9.5 immunoreactivity was found in only 9 cases (35%). None of the SCC cases showed CD99 immunostaining. No CD99 immunoreact…

AdultMalePathologymedicine.medical_specialtySkin NeoplasmsCD9912E7 AntigenMalignancyDiagnosis DifferentialAntigens CDBiomarkers TumorCarcinomamedicineHumansMelanomaAgedHistiocytoma Benign Fibrousbusiness.industryMelanomaAtypical fibroxanthomaGeneral MedicineMiddle Agedmedicine.diseaseEpidermoid carcinomaCarcinoma Squamous CellImmunohistochemistryFemaleThiolester HydrolasesbusinessCell Adhesion MoleculesUbiquitin ThiolesteraseImmunostainingAmerican Journal of Clinical Pathology
researchProduct

Operative management of epidural tumors of the spine

1994

Seventy-two patients with neoplastic involvement of the vertebral column were operated on between 1986 and 1991. In the course of 79 operations anterior decompression and stabilization alone were performed in 3 cases, while ventrodorsal spondylodesis was carried out in 10 individuals. The remainder of the patients underwent exclusively dorsal decompression and stabilization, mainly with the Cotrel-Dubousset instrumentation (CDI). No external spinal support was required following posterior fixation by CDI alone or in combination with ventral spondylodesis. Forty patients suffered from neurological deficits preoperatively, 20 of them being unable to walk, in most cases owing to severe vertebr…

AdultMalemedicine.medical_specialtySkin Neoplasmsgenetic structuresDecompressionEpidural TumorsPosterior fixationmedicineHumansOrthopedics and Sports MedicineAgedRetrospective StudiesFixation (histology)Aged 80 and overHistiocytoma Benign Fibrousbusiness.industryAnterior decompressionGeneral MedicineMiddle AgedSurgerymedicine.anatomical_structureAnesthesiaOrthopedic surgeryFemaleSurgeryEpidural NeoplasmsVertebral collapseMultiple MyelomabusinessVertebral columnArchives of Orthopaedic and Trauma Surgery
researchProduct

Malignant fibrous histiocytoma of the renal capsule

1981

We report about an extremely rare case of malignant fibrous histiocytoma (MFH) of the renal capsule. The tumor is composed of fibroblast-like cells arranged in a storiform pattern and histiocyte-like cells with multinucleated giant cells, both showing no iron reaction. Characteristic of the histiocytic quality of the tumor are numerous PAS-positive intracytoplasmic droplets which can be identified as erythrophagosomes only under the electron microscope. Emphasis is put on the preoperative differential diagnosis of the tumor from renal cell carcinoma as well as on its histogenesis and prognosis.

Cancer Researchmedicine.medical_specialtyPathologyHistogenesislaw.inventionDiagnosis DifferentialRenal capsulelawRenal cell carcinomaInternal medicinemedicineHumansHistiocyteAgedHematologyHistiocytoma Benign Fibrousbusiness.industryGeneral Medicinemedicine.diseaseKidney Neoplasmsmedicine.anatomical_structureOncologyGiant cellFemaleDifferential diagnosisElectron microscopebusinessJournal of Cancer Research and Clinical Oncology
researchProduct

In regard to “A tale of two clones: Caldesmon staining in the differentiation of cutaneous spindle-cell neoplasms”

2018

LeiomyosarcomaPathologymedicine.medical_specialtyHistologyCellDermatologyH caldesmonPathology and Forensic Medicine030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineSmooth musclemedicineHumansHistiocytoma Benign FibrousStaining and LabelingbiologyAtypical fibroxanthomaCell Differentiationmedicine.diseaseStainingCaldesmonmedicine.anatomical_structure030220 oncology & carcinogenesisbiology.proteinCalmodulin-Binding ProteinsJournal of Cutaneous Pathology
researchProduct

Value of nude mice xenografts in the expression of cell heterogeneity of human sarcomas of bone and soft tissue.

1988

Summary Nude mice xenotransplants have been performed on human primary sarcomas of bone and soft tissues in order to delve into the cell heterogeneity of these neoplasms. Particular emphasis has been given to the group of small round blue cell sarcomas (Ewing's sarcomas and peripheral neuroectodermal tumors). Out of 31 xenotransplanted sarcomas, 16 cases have grown positively, and many of them continue to be transferred into nude mice on a regular time basis, being presently considered as fully established nude lines. Here we report the results of such a system, which has been followed with optical, electron microscopical, immunohistochemical and cytogenetic techniques. Osteosarcomas make u…

MalePathologymedicine.medical_specialtyCellTransplantation HeterologousMice NudeBone NeoplasmsSoft Tissue NeoplasmsSarcoma EwingBiologyPathology and Forensic MedicineMicemedicineAnimalsOsteosarcomaHistiocytoma Benign FibrousMesenchymal stem cellSoft tissueCell Biologymedicine.diseaseCytokeratin positivemedicine.anatomical_structureImmunohistochemistrySarcomaNeoplasm TransplantationCytogenetic TechniquesPathology, research and practice
researchProduct

h-caldesmon immunoreactivity in atypical fibroxanthoma: implications for the differential diagnosis.

2017

MalePathologymedicine.medical_specialtySkin NeoplasmsSkin DiseasesH caldesmonPathology and Forensic MedicineDiagnosis Differential030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinemedicineXanthomatosisHumansAgedAged 80 and overHistiocytoma Benign Fibrousbusiness.industryAtypical fibroxanthomamedicine.diseaseImmunohistochemistry030220 oncology & carcinogenesisImmunohistochemistryCalmodulin-Binding ProteinsFemaleDifferential diagnosisbusinessPathology
researchProduct

FU-3 monoclonal antibody: a specific marker for malignant fibrous histiocytoma? An analysis of 32 malignant soft tissue and bone sarcomas.

1994

An immunohistochemical study on frozen sections was carried out on 51 malignant tumours of soft tissue and bone using the FU-3 monoclonal antibody. This antibody is claimed to be specific for malignant fibrous histiocytoma (MFH) and liposarcoma and for normal and tumour cells located in perivascular fields. The results show a lack of specificity in MFH staining: several malignant tumours such as synovial sarcoma, fibrosarcoma, rhabdomyosarcoma, osteogenic sarcoma, and including an anaplastic malignant melanoma, presented positive staining somewhat similar to that found in MFH. The value of this antibody in the differential diagnosis of MFH is doubtful. It might be useful to recognize a comm…

Pathologymedicine.medical_specialtyHistiocytoma Benign Fibrousbusiness.industrySoft tissueAntibodies MonoclonalBone NeoplasmsSarcomaCell BiologyGeneral MedicineBone SarcomaLiposarcomamedicine.diseaseImmunohistochemistrySynovial sarcomaPathology and Forensic MedicinemedicineImmunohistochemistryHumansSarcomaFibrosarcomabusinessRhabdomyosarcomaMolecular BiologyVirchows Archiv : an international journal of pathology
researchProduct

Nonepithelial skin tumors with multinucleated giant cells

2013

Recognition of the different types of multinucleated giant cells in neoplastic and pseudotumoral lesions of the skin may be helpful in the differential diagnosis of these tumors. In this review, we will analyze the different types of multinucleated giant cells that can be found in nonepithelial cutaneous tumors and, more importantly, the clinicopathological context in which they are found. Touton giant cells are typically present in juvenile xanthogranuloma, necrobiotic xanthogranuloma, and some subtypes of xanthomas. Giant cells with a ground glass appearance are typically present in the solitary reticulohistiocytoma and multicentric reticulohistiocytosis. Osteoclast-like cells are found i…

Pathologymedicine.medical_specialtySkin NeoplasmsHistiocytosis Non-Langerhans-CellJuvenile xanthogranulomaSoft Tissue NeoplasmsFibromaBiologyGiant CellsPathology and Forensic MedicineTouton giant cellXanthomatosismedicineHumansGiant Cell TumorsNecrobiotic xanthogranulomaHistiocytoma Benign FibrousPlexiform fibrohistiocytic tumorDermatofibrosarcomaGiant Cell TumorsAtypical fibroxanthomamedicine.diseaseGiant cellLipomaPleomorphic lipomaXanthogranuloma JuvenileSeminars in Diagnostic Pathology
researchProduct

Analysis of p53 and mdm2 proteins in malignant fibrous histiocytoma in absence of gene alteration: prognostic significance.

2000

TP53 and MDM2 genes and their protein expression were evaluated in frozen and paraffin-embedded tissue from 27 patients with malignant fibrous histiocytoma to elucidate the relationship between them, their implication in tumor progression mechanisms and their possible diagnostic-prognostic value in malignant fibrous histiocytoma. Single-strand conformation polymorphism analysis and direct sequencing of polymerase chain reaction-amplified DNA were used to establish two TP53 mutations (7.4%): a point mutation and a 63-bp duplication. Amplification of the MDM2 gene was observed in two tumors (7.4%) by means of Southern-blot analysis, one of them also carrying the TP53 point mutation. Immunohis…

Tumor suppressor geneBlotting WesternSoft Tissue NeoplasmsBiologyPolymerase Chain ReactionPathology and Forensic MedicineImmunoenzyme TechniquesMiceProto-Oncogene ProteinsGene duplicationGene expressionAnimalsHumansneoplasmsMolecular BiologyGeneTP53 Gene MutationPolymorphism Single-Stranded ConformationalCell NucleusMice Inbred BALB CHistiocytoma Benign FibrousPoint mutationNuclear ProteinsSingle-strand conformation polymorphismProto-Oncogene Proteins c-mdm2Cell BiologyGeneral MedicineDNA NeoplasmMolecular biologyNeoplasm ProteinsSurvival RateBlotting SouthernTumor progressionMutationCancer researchNeoplasm Recurrence LocalTumor Suppressor Protein p53Virchows Archiv : an international journal of pathology
researchProduct

The Man Behind the Eponym: Hans Biberstein and Follicular Hyperplasia Overlying Dermatofibroma

2009

Hans Biberstein first described the basaloid follicular hyperplasia overlying dermatofibromas in 1923 and published his extensive observations on the subject in 1931. Part of Josef Jadassohn's department in Breslau, he was forced to leave German by the National Socialist regime and spent the rest of his career in New York. After a hiatus of 30 years, the dermatopathologic literature once again began addressing his seminal finding but never gave him proper credit. We suggest Biberstein's sign as an appropriate term for basaloid follicular hyperplasia overlying a dermatofibroma and as a small tribute to a pioneer dermatopathologist.

medicine.medical_specialtyPathologyHyperplasiaSkin Neoplasmsmusic.instrumentHistiocytoma Benign Fibrousbusiness.industryEponymDermatologyGeneral MedicineHistory 20th Centurymedicine.diseaseDermatofibromaDermatologyFollicular hyperplasiaPathology and Forensic MedicinePathologymedicineFibromabusinessmusicThe American Journal of Dermatopathology
researchProduct